A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer
Clinical trial NCT07679360 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07679360
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2030-12-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.